CDH1 and cancer: A majority of cancers (21 out of 32) showed a strong positive correlation of PD-L1 with the mesenchymal related metrics (ZEB1, SLUG, Hallmark EMT, mesenchymal score, and M-E score) while showing an intermediate to strong negative correlation with the epithelial ones (CDH1, GRHL2, and epithelial score), thereby endorsing our model predictions.